Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,724 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST).
Yamamoto R, Kusumi E, Kami M, Yuji K, Hamaki T, Saito A, Murasgihe N, Hori A, Kim SW, Makimoto A, Ueyama J, Tanosaki R, Miyakoshi S, Mori S, Morinaga S, Heike Y, Taniguchi S, Masuo S, Takaue Y, Mutou Y. Yamamoto R, et al. Among authors: kim sw. Bone Marrow Transplant. 2003 Dec;32(11):1089-95. doi: 10.1038/sj.bmt.1704261. Bone Marrow Transplant. 2003. PMID: 14625581
High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma.
Tanimoto TE, Kusumi E, Hamaki T, Yuji K, Ueyama J, Miyakoshi S, Morinaga S, Kami M, Kanda Y, Ando T, Yoshihara S, Masuo S, Kim SW, Nakai K, Tobinai K, Tanosaki R, Mineishi S, Takaue Y, Muto Y. Tanimoto TE, et al. Among authors: kim sw. Bone Marrow Transplant. 2003 Jul;32(2):131-7. doi: 10.1038/sj.bmt.1704118. Bone Marrow Transplant. 2003. PMID: 12838276 Clinical Trial.
Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kojima R, Kami M, Kim SW, Murashige N, Kishi Y, Hori A, Imataki O, Hamaki T, Sakiyama M, Masuo S, Fujisawa Y, Makimoto A, Heike Y, Tanosaki R, Takaue Y. Kojima R, et al. Among authors: kim sw. Bone Marrow Transplant. 2003 Aug;32(4):439-42. doi: 10.1038/sj.bmt.1704146. Bone Marrow Transplant. 2003. PMID: 12900783
Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation.
Saito T, Kanda Y, Nakai K, Kim SW, Arima F, Kami M, Tanosaki R, Tobinai K, Wakasugi H, Heike Y, Mineishi S, Takaue Y. Saito T, et al. Among authors: kim sw. Bone Marrow Transplant. 2003 Sep;32(6):601-8. doi: 10.1038/sj.bmt.1704205. Bone Marrow Transplant. 2003. PMID: 12953133 Clinical Trial.
Successful reduced-intensity stem cell transplantation (RIST) with mismatched cord blood in a 70-year-old patient with severe aplastic anemia (SAA).
Kusumi E, Miyakoshi S, Murashige N, Katayama Y, Kim SW, Yuji K, Kami M, Ueyama J, Morinaga S, Masuo S, Taniguchi S, Takaue Y, Muto Y. Kusumi E, et al. Among authors: kim sw. Bone Marrow Transplant. 2003 Dec;32(11):1111-2. doi: 10.1038/sj.bmt.1704310. Bone Marrow Transplant. 2003. PMID: 14625587 No abstract available.
Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor.
Kusumi E, Kami M, Yuji K, Hamaki T, Murashige N, Hori A, Kojima R, Kishi Y, Kim SW, Ueyama J, Miyakoshi S, Tanosaki R, Morinaga S, Mori S, Heike Y, Muto Y, Masuo S, Taniguchi S, Takaue Y. Kusumi E, et al. Among authors: kim sw. Bone Marrow Transplant. 2004 Apr;33(7):697-702. doi: 10.1038/sj.bmt.1704425. Bone Marrow Transplant. 2004. PMID: 14755317
Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies.
Hamaki T, Kami M, Kim SW, Onishi Y, Kishi Y, Murashige N, Hori A, Kojima R, Sakiyama M, Imataki O, Heike Y, Tanosaki R, Masuo S, Miyakoshi S, Taniguchi S, Tobinai K, Takaue Y. Hamaki T, et al. Among authors: kim sw. Bone Marrow Transplant. 2004 May;33(9):891-900. doi: 10.1038/sj.bmt.1704477. Bone Marrow Transplant. 2004. PMID: 15048142 Clinical Trial.
A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in Japan.
Imataki O, Kami M, Kim SW, Gotoh M, Komaba S, Kasai M, Hashino S, Naito K, Masuda M, Anan K, Teshima H, Togitani K, Inoue T, Nishimura M, Adachi Y, Fukuhara T, Yamashita T, Uike N, Kobayashi Y, Hamaguchi M, Higuchi M, Kawakami K, Takaue Y. Imataki O, et al. Among authors: kim sw. Bone Marrow Transplant. 2004 Jun;33(12):1173-9. doi: 10.1038/sj.bmt.1704526. Bone Marrow Transplant. 2004. PMID: 15094754
Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0.
Sakiyama M, Kami M, Hori A, Imataki O, Hamaki T, Murashige N, Kobayashi K, Kishi Y, Kojima R, Kim SW, Kusumi E, Yuji K, Miyakoshi S, Mori S, Tanosaki R, Taniguchi S, Takaue Y; Tokyo SCT Consortium. Sakiyama M, et al. Among authors: kim sw. Bone Marrow Transplant. 2004 Nov;34(9):787-94. doi: 10.1038/sj.bmt.1704673. Bone Marrow Transplant. 2004. PMID: 15361909
Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantation.
Chizuka A, Kami M, Kanda Y, Murashige N, Kishi Y, Hamaki T, Kim SW, Hori A, Kojima R, Mori SI, Tanosaki R, Gomi H, Takaue Y. Chizuka A, et al. Among authors: kim sw. Bone Marrow Transplant. 2005 Mar;35(6):577-82. doi: 10.1038/sj.bmt.1704830. Bone Marrow Transplant. 2005. PMID: 15665840
9,724 results